Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-05-01FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for Terazosin hydrochloride from Jubilant Cadista Pharmaceuticals, resulting in labeling changes.
-
CLINICAL_TRIALS research · 2007-05-01Clinical Trial Update: Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate [Phase 1]
Ex vivo evaluation of the ProstaPlant Prostate Stent for benign prostatic hyperplasia in human prostate tissue is described in this Phase 1 …
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Kinetics of the Finasteride Prostate Induced Apoptosis [Phase 4]
A Phase 4 clinical trial update examining the kinetics of finasteride-induced effects on the prostate in Benign Prostatic Hyperplasia. The c…
-
CLINICAL_TRIALS research · 2007-04-18Clinical Trial Update: Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) [NA]
This is a clinical trial update evaluating dutasteride to improve perioperative and long-term outcomes after photoselective vaporization of …
-
FDA approval · 2007-03-29FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma US Corp. The action confirms regulatory clearance r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-02-28FDA Approved: FINASTERIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories' generic finasteride (Original Application) for indications including benign prostatic hyperplasia and…
-
CLINICAL_TRIALS research · 2007-02-05Clinical Trial Update: Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
This clinical trial update discusses Annexin A3 as a protein-based biomarker for non-invasive molecular diagnostics of prostate carcinoma, r…
-
FDA approval · 2006-12-15FDA Approved: FINASTERIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a generic version of finasteride through an original application submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2006-12-15FDA Approved: DOXAZOSIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for doxazosin mesylate (DOXAZOSIN) submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2006-11-16FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) submitted by Advanz Pharma (US) Corp.
-
FDA approval · 2006-10-23FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Cialis (tadalafil) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2006-10-03Clinical Trial Update: Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) [Phase 2]
A Phase 2 trial of photodynamic therapy for benign prostatic hyperplasia sponsored by QLT Inc. was terminated.
-
FDA approval · 2006-07-28FDA Approved: FINASTERIDE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories' generic finasteride as an original ANDA (ANDA 076436).
-
FDA approval · 2006-06-07FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for doxazosin (generic), confirming regulatory clearance related to this generic p…